| 2NYY | A:885-1079 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1 |
| 2NZ9 | B:885-1079; B:885-1079 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2 |
| 2VU9 | A:885-1079 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B |
| 2VUA | A:885-1079 | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN |
| 1S0B | A:871-1065 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0 |
| 1S0C | A:871-1065 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0 |
| 1S0D | A:871-1065 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5 |
| 1S0E | A:871-1065 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0 |
| 1S0F | A:871-1065 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0 |
| 1Z0H | B:871-1065; B:871-1065 | N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B |
| 2NM1 | A:872-1066 | STRUCTURE OF BONT/B IN COMPLEX WITH ITS PROTEIN RECEPTOR |
| 2NP0 | A:871-1065 | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN |
| 3N7K | B:880-1080; B:880-1080 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN |
| 3R4S | B:880-1080; B:880-1080 | CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES |
| 3R4U | B:880-1080; B:880-1080 | CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES |
| 3N7J | A:876-1067 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN |
| 3OBR | A:876-1067 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN |
| 3OBT | A:876-1067 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D LIGAND BINDING DOMAIN IN COMPLEX WITH N-ACETYLNEURAMINIC ACID |
| 3OGG | A:876-1067 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN D |
| 3RMX | D:876-1067; D:876-1067; D:876-1067; D:876-1067 | CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT |
| 3RMY | D:876-1067; D:876-1067; D:876-1067; D:876-1067 | CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT |
| 2VXR | A:877-1074 | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN |
| 3MPP | G:877-1074 | BOTULINUM NEUROTOXIN TYPE G RECEPTOR BINDING DOMAIN |
| 3PME | A:880-1071 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN C/D MOSAIC SEROTYPE |
| 3N7L | A:876-1076 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D/C VPI 5993 BINDING DOMAIN |
| 3N7M | A:876-1076 | CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995 |
)
)